These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 15918296

  • 1. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
    Ferreira MB, Santos AS, Santos MC, Carlos ML, Barbosa MA, Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
    [Abstract] [Full Text] [Related]

  • 2. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon.
    Marcucci F, Passalacqua G, Canonica GW, Frati F, Salvatori S, Di cara G, Petrini I, Bernini M, Novembre E, Bernardini R, Incorvaia C, Sensi LG.
    Respir Med; 2007 Jul; 101(7):1600-8. PubMed ID: 17482451
    [Abstract] [Full Text] [Related]

  • 3. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
    Marcucci F, Sensi L, Di Cara G, Salvatori S, Bernini M, Pecora S, Burastero SE.
    Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy in allergic rhinitis.
    Palma-Carlos AG, Spinola-Santos A, Ferreira MB, Santos MC, Palma-Carlos ML.
    Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Humoral mucosal immunity in allergic rhinitis].
    Kramer MF, Jordan TR, Pfrogner E, Rasp G.
    Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
    Tsai JJ, Liao EC, Tsai FH, Hsieh CC, Lee MF.
    J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of eosinophil cationic protein release in mite-allergic rhinitis after specific nasal provocation.
    Branco-Ferreira M, Palma-Carlos ML, Santos MC, Lopes AP, Palma-Carlos AG.
    Allerg Immunol (Paris); 1998 Apr; 30(4):104, 107-11. PubMed ID: 9631691
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P, Tillie-Leblond I, Malaquin F, Durieu J, Wallaert B, Tonnel AB.
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [Abstract] [Full Text] [Related]

  • 13. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C, Schubert R, Kopp M, Ersfeld Y, Rosewich M, Kuehr J, Kamin W, Berg AV, Wahu U, Zielen S.
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [Abstract] [Full Text] [Related]

  • 14. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
    Rondón C, Fernández J, López S, Campo P, Doña I, Torres MJ, Mayorga C, Blanca M.
    J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor in allergen-induced nasal inflammation.
    Choi GS, Park HJ, Hur GY, Choi SJ, Shin SY, Ye YM, Park HS.
    Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
    Tahamiler R, Saritzali G, Canakcioglu S, Ozcora E, Dirican A.
    ORL J Otorhinolaryngol Relat Spec; 2008 May; 70(3):144-50. PubMed ID: 18391573
    [Abstract] [Full Text] [Related]

  • 17. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D, Keck T, Riechelmann H.
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [Abstract] [Full Text] [Related]

  • 18. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 19. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D, Akmanlar N, Güneşer S, Burgut R, Yilmaz M, Buğdayci R, Aksungur P.
    Allergol Immunopathol (Madr); 1999 Sep; 27(6):309-17. PubMed ID: 10611556
    [Abstract] [Full Text] [Related]

  • 20. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
    Kasperska-Zajac A, Brzoza Z, Rogala B.
    Vaccine; 2007 May 04; 25(18):3595-8. PubMed ID: 17291641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.